31 related articles for article (PubMed ID: 3859248)
1. Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Takenaka T; Itoh K; Suzuki T; Utsunomiya A; Matsuda S; Chou T; Sai T; Sano M; Konda S; Ohno T; Mikuni C; Deura K; Yamada T; Mizorogi F; Nagoshi H; Tomonaga M; Hotta T; Kawano K; Tsushita K; Hirano M; Shimoyama M;
Int J Hematol; 2004 Feb; 79(2):165-73. PubMed ID: 15005346
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
Kobayashi T; Tanaka I; Shirakawa S; Fujiwara Y; Hirota Y; Kobayashi M; Ohno R; Yamada H; Mitomo Y; Yamamoto M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M
Gan To Kagaku Ryoho; 1986 May; 13(5):1915-20. PubMed ID: 3458432
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of haematological malignancies. Prognostic significance.
Klener P
Acta Univ Carol Med Monogr; 1979; 90():7-127. PubMed ID: 400423
[No Abstract] [Full Text] [Related]
10. Nitrosoureas: a reappraisal of clinical trials.
Katz ME; Glick JH
Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
[TBL] [Abstract][Full Text] [Related]
11. [Analysis for telomerase activity in various hematologic disorders].
Kosugi H; Saito H
Nihon Rinsho; 1998 May; 56(5):1316-21. PubMed ID: 9613144
[TBL] [Abstract][Full Text] [Related]
12. [Experience with Cefobid in severe infections complicating immunodeficiency diseases].
István L; Bodnár M; Marton E; Lakatos F; Végh G
Orv Hetil; 1989 Nov; 130(45):2419-24. PubMed ID: 2694059
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]